ERS/TSANZ Task Force Statement on the Management of Reproduction and Pregnancy in Women with Airways Diseases.
This Statement outlines a review of the literature and expert opinion concerning management of reproduction and pregnancy in women with airways diseases. The Statement represents the first collaboration of the European Respiratory Society (ERS) and the Thoracic Society of Australia and New Zealand (TSANZ) to develop such documents. This Statement covers airways diseases - namely Asthma, Cystic Fibrosis (CF) and non-CF Bronchiectasis. Many women with these diseases are now living into reproductive age with some developing moderate to severe impairment of lung function in early adulthood. The Statement covers aspects of fertility, management during pregnancy, effects of drugs and issues during delivery. The Statement summarises current knowledge but does not make recommendations. This Statement will not discuss the physiological changes occurring in pregnancy, such as the changes in airway physiology, resting ventilation and sleep nor other forms of lung disease such as pulmonary fibrosis, pulmonary hypertension, gastro-oesophageal reflux-related lung disease or issues with nicotine consumption.